[Dynamic] Wang Jianxin, Chairman of Dongtie Group, and his delegation inspected the Yuhuan Datie project
Source:
|
Author:管理员
|
Published time: 2021-07-16
|
151 Views
|
Share:
On July 15, 2021 at 14:00, Wang Jianxin, Chairman of Dongtie Group, Yang Yunzheng, Vice President of Group Marketing, and all members of the marketing system visited the Yuhuan Metro project
On July 15, 2021 at 14:00, Chairman Wang Jianxin of Dongtie Group, Vice President of Group Marketing Yang Yunzheng, and all members of the marketing system visited the Yuhuan Datie project. Accompanied by President Wang Zhifeng, Vice Leader of the project team Wang Jianlin, Equipment Team Ren Bin, Zhang Juntao, and the person in charge of the general contractor, they visited and inspected the infrastructure engineering and equipment installation progress of the Yuhuan Datie project, and provided on-site guidance for the project team's work.The chairman and his team carefully inquired about the progress of the Yuhuan Datie infrastructure project and conducted on-site inspections of the construction quality. At the project site, Wang Jianlin and Ren Bin reported in detail to the chairman on the infrastructure construction project and equipment installation and commissioning of Yuhuan Datie.
After the on-site inspection, the chairman and his team came to the temporary office of the Yuhuan Datie Project Team to listen to the report of the Yuhuan Datie Project Team on the market development progress and marketing ideas of Yuhuan Datie's new products. The group chairman and marketing vice president highly recognized the innovation of Yuhuan Datie's marketing ideas and affirmed Yuhuan Datie's active pursuit of market and product breakthroughs, At the same time, it has injected strong confidence into the market positioning of Yuhuan Datie to carry out high value-added precision processing business.
With the full support of the leaders of the group company and the personal leadership of the president, Yuhuan Metro will continue to seize the construction period, complete the key milestones, and spare no effort to accelerate the trial production!
